TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Resonance Health Ltd ( (AU:RHT) ) is now available.
Resonance Health Limited reported a significant increase in revenue by 29% to $11.07 million for the year ending June 30, 2025, compared to the previous year. However, the company faced a net loss of $1.73 million, a sharp decline from the previous year’s profit of $169,303. This financial downturn, despite increased revenues, indicates challenges in managing operational costs or other financial pressures, impacting the company’s profitability and potentially affecting stakeholder confidence.
More about Resonance Health Ltd
Resonance Health Limited operates in the healthcare industry, specializing in the development and commercialization of imaging-based diagnostic technologies. The company focuses on providing non-invasive medical imaging solutions to enhance the diagnosis and management of human diseases, particularly in liver health.
Average Trading Volume: 324,489
Technical Sentiment Signal: Sell
Current Market Cap: A$19.3M
Learn more about RHT stock on TipRanks’ Stock Analysis page.